Hepatitis B surface antigen (HBsAg) is considered the best marker for the diagnosis of hepatitis B virus (HBV) infection. Mutations of the s gene involving amino acid substitutions within the a determinant could affect the sensitivity of diagnostic tests. In the present study, HBsAg mutants were detected in 3 immunocompromised patients, previously found to be HBsAg negative and anti-HBs positive. All patients had high levels of HBV-DNA, whereas HBsAg tests gave discordant results. Immunosuppression can cause viral reactivation of occult HBV infection in these patients and favour the selection of HBsAg a determinant mutants. 2010 S. Karger AG, Basel.

Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays / Veropalumbo, E.; Marrone, A.; Vallefuoco, L.; Perruolo, G.; Orlando, Raffaele; Scordino, F.; Tosone, Grazia; Zampino, R.; Trani, B.; Genovese, Arturo; Spadaro, Giuseppe; D'Orio, Concetta; Portella, Giuseppe. - In: INTERVIROLOGY. - ISSN 0300-5526. - STAMPA. - 53:3(2010), pp. 183-187.

Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays.

Perruolo G.;ORLANDO, RAFFAELE;TOSONE, GRAZIA;GENOVESE, ARTURO;SPADARO, GIUSEPPE;D'ORIO, CONCETTA;PORTELLA, GIUSEPPE
2010

Abstract

Hepatitis B surface antigen (HBsAg) is considered the best marker for the diagnosis of hepatitis B virus (HBV) infection. Mutations of the s gene involving amino acid substitutions within the a determinant could affect the sensitivity of diagnostic tests. In the present study, HBsAg mutants were detected in 3 immunocompromised patients, previously found to be HBsAg negative and anti-HBs positive. All patients had high levels of HBV-DNA, whereas HBsAg tests gave discordant results. Immunosuppression can cause viral reactivation of occult HBV infection in these patients and favour the selection of HBsAg a determinant mutants. 2010 S. Karger AG, Basel.
2010
Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays / Veropalumbo, E.; Marrone, A.; Vallefuoco, L.; Perruolo, G.; Orlando, Raffaele; Scordino, F.; Tosone, Grazia; Zampino, R.; Trani, B.; Genovese, Arturo; Spadaro, Giuseppe; D'Orio, Concetta; Portella, Giuseppe. - In: INTERVIROLOGY. - ISSN 0300-5526. - STAMPA. - 53:3(2010), pp. 183-187.
File in questo prodotto:
File Dimensione Formato  
Intervirology- Immunocompromised pts HBV.pdf

non disponibili

Tipologia: Altro materiale allegato
Licenza: Accesso privato/ristretto
Dimensione 115.14 kB
Formato Adobe PDF
115.14 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/364303
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact